Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  AMMS-CanSino to Start Clinical Trial of China Ebola Vaccine
  SciClone Pharma Gains China Rights for Two CV Drugs in $50 Million Deal
  Hutchison MediPharma Starts Phase III Trial of Cancer Drug
  Ypsomed to Make Diabetes Injection Pens in China
  Neusoft Raises $610 Million to Support Healthcare Operations
  China Pioneer to Provide NeutroPhase for Free to Patients with Flesh-Eating Disease
  Taiwan's TWi Biotech to Start Clinical Trial of Gout Treatment
  Milestone China to Distribute Epidural Device in China
  BeyondSpring to Start China-US Phase III Trial of Novel Cancer Drug
  Cipla Sells Stake in Jiangsu Cdymax Pharma for $18.5 Million


Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors